The nuclear hormone receptor DAF-12 acts as the switch between continuous development or arrest at the dauer diapause during the L2 stage. It also works in the heterochronic circuit, promoting L3-stage specific developmental programs. Another heterochronic factor, the zinc finger protein LIN-29 acts during L4 to promote terminal differentiation of various tissues like gonad or hypodermis, a function referred to as the larval-to-adult switch. Despite this terminal position, here we present evidence that LIN-29 is involved in transcriptional activation of the
let-7 sister
mir-84, which was thought to act at an earlier step. Previously, we had shown DAF-12 and ligand dependent activation of
mir-84 promoter constructs in human cell culture and in worms. We wondered whether any of the heterochronic factors could serve as DAF-12 co-activators to augment transcription. Remarkably, we found that co-transfection of LIN-29 increased DAF-12 dependent transcription two-fold, but had no such activity alone, suggesting LIN-29 may be a DAF-12 co-activator. Accordingly, point mutation of DAF-12 response elements strongly decreased DAF-12 and ligand dependent activation as well as the co-activator effect, The DNA-motive that LIN-29 binds to is unknown, but EMSA with an oligo containing two functional DAF-12 sites show no LIN-29 binding, making it unlikely that LIN-29 can bind directly to DAF-12 response elements. Taken together, the experiments suggest that LIN-29 works through DAF-12 to exert these transcriptional effects. The
mir-84 promoter also shows DAF-12 and LIN-29 dependence in vivo. In particular, the
lin-29 null mutants exhibited decreased pharyngeal
mir-84p::GFP expression, even below the level observed in a
daf-12 null. Moreover, a
lin-29,
daf-12 double null nearly lost all GFP expression. These in vivo data are consistent with the notion that LIN-29 acts through DAF-12 and its response elements, but also hint at a DAF-12 independent function of LIN-29 on the
mir-84 promoter. The placement of LIN-29 upstream of
mir-84 inverts its conventional placement as the terminal factor in the heterochronic pathway. Interestingly, Hayes et al showed that
mir-84 over expression can suppress
lin-29 for supernumerary molting heterochronic phenotypes. This, together with the data presented here, suggests that LIN-29 could drive terminal differentiation in the hypodermis through activating
mir-84 expression, placing miR-84 downstream of LIN-29 to the very end of the heterochronic signaling cascade. We are currently testing this hypothesis.